Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Reproduced from Civiqs; Chart: Axios Visuals

Americans of all ages, education levels, genders, races and political parties say they're more likely than not to get the coronavirus vaccine — except Republicans.

Why it matters: Vaccine hesitancy is higher among white Republicans than any other demographic group, and it hasn't been improving much as the vaccination effort continues, according to Civiqs polling.

By the numbers: 41% of Republicans say they don't plan to get a vaccine if it's available to them. Only 33% say they do plan to get vaccinated.

  • 70% of Democrats and a plurality of independents (47%) say they plan to get vaccinated.
  • White Americans are now less likely than Black and Latino Americans to say they plan to get the vaccine.

Between the lines: States' levels of vaccine hesitancy correlate strongly with their politics, according to CoVaxxy, a project by Indiana University's Observatory on Social Media.

  • Blue states have lower rates of vaccine refusal than red states, and battleground states are generally somewhere in the middle.
  • Wyoming, North Dakota and Mississippi have some of the highest rates of vaccine refusal, while Rhode Island, Massachusetts and Connecticut have some of the lowest.

The bottom line: The virus doesn't care about politics, and it certainly won't confine itself to states with the largest unvaccinated populations.

  • High rates of vaccine hesitancy among any group threatens our collective progress against the pandemic, meaning that it's just as important to reach white Republicans as it is to reach other hesitant groups.

Go deeper

Feb 24, 2021 - Health

Moderna says vaccine for South Africa COVID-19 variant ready for testing

A doctor drawing the Moderna vaccine into syringes in Central Falls, Rhode Island, on Feb. 13. Photo: Joseph Prezioso

Vaccine producer Moderna announced Wednesday it is sending doses of a new vaccine designed to better protect against the coronavirus variant first discovered in South Africa to the National Institutes of Health for a Phase 1 clinical trial.

Why it matters: The trial is a major step toward producing and distributing a vaccine specifically designed for the South Africa variant, which may spread faster and more easily than the original coronavirus strain, according to the Centers for Disease Control and Prevention.

Feb 24, 2021 - Health

Poll: 60% of Republicans back Biden's $1.9 trillion relief package

President Biden and Vice President Kamala Harris meet with labor leaders to discuss coronavirus relief on Feb. 17. Photo: Pete Marovich/The New York Times/Bloomberg via Getty Images

60% of Republicans surveyed in a new Morning Consult/Politico poll either strongly support or somewhat support President Biden's $1.9 trillion coronavirus relief package.

Why it matters: The poll suggests GOP lawmakers' criticisms of the plan have failed to gain traction with their voters, as the massive proposal has gained bipartisan support amid enduringly high unemployment and economic pain.

Updated Feb 24, 2021 - Health

FDA analysis finds Johnson & Johnson COVID vaccine is safe and effective

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration's staff released a briefing document on Wednesday endorsing Johnson & Johnson's one-shot coronavirus vaccine as safe and effective.

The latest: Assuming the FDA issues an emergency use authorization "without delay," meaning as soon as this weekend, White House coronavirus coordinator Jeff Zients said J&J will have 3 million to 4 million ready for distribution next week.